My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 117

    1.

    Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy.

    Jonas JB, Hayler JK, Panda-Jonas S.

    Br J Ophthalmol. 2000 Sep;84(9):1064-7.PMID: 10966969 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy.

    Jonas JB, Hayler JK, Söfker A, Panda-Jonas S.

    Am J Ophthalmol. 2001 Apr;131(4):468-71.PMID: 11292410 [PubMed - indexed for MEDLINE]Related articles

    3.

    Intravitreal triamcinolone acetonide as an additional tool in pars plana vitrectomy for proliferative diabetic retinopathy.

    Jonas JB, Söfker A, Degenring R.

    Eur J Ophthalmol. 2003 Jun;13(5):468-73.PMID: 12841570 [PubMed - indexed for MEDLINE]Related articles

    4.

    Intravitreal triamcinolone for treatment of complicated proliferative diabetic retinopathy and proliferative vitreoretinopathy.

    Munir WM, Pulido JS, Sharma MC, Buerk BM.

    Can J Ophthalmol. 2005 Oct;40(5):598-604.PMID: 16391623 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Cataract surgery combined with intravitreal injection of triamcinolone acetonide.

    Jonas JB, Kreissig I, Budde WM, Degenring RF.

    Eur J Ophthalmol. 2005 May-Jun;15(3):329-35.PMID: 15945000 [PubMed - indexed for MEDLINE]Related articles

    6.

    Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone.

    Jonas JB, Hayler JK, Söfker A, Panda-Jonas S.

    J Glaucoma. 2001 Aug;10(4):284-7.PMID: 11558812 [PubMed - indexed for MEDLINE]Related articles

    7.

    Long-term clinical outcomes and therapeutic benefits of triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy: a case study.

    Ueno A, Enaida H, Hata Y, Hisatomi T, Nakamura T, Mochizuki Y, Sakamoto T, Ishibashi T.

    Eur J Ophthalmol. 2007 May-Jun;17(3):392-8.PMID: 17534822 [PubMed - indexed for MEDLINE]Related articles

    8.

    Triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy.

    Furino C, Micelli Ferrari T, Boscia F, Cardascia N, Recchimurzo N, Sborgia C.

    Retina. 2003 Dec;23(6):771-6.PMID: 14707825 [PubMed - indexed for MEDLINE]Related articles

    9.

    Anti-inflammatory efficacy of a single posterior subtenon injection of triamcinolone acetonide versus prednisolone acetate 1% eyedrops after pars plana vitrectomy.

    Paccola L, Jorge R, Barbosa JC, Costa RA, Scott IU.

    Acta Ophthalmol Scand. 2007 Sep;85(6):603-8. Epub 2007 Apr 24.PMID: 17459031 [PubMed - indexed for MEDLINE]Related articles

    10.

    Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study.

    Scott IU, Flynn HW Jr, Murray TG, Feuer WJ; Perfluoron study group.

    Am J Ophthalmol. 2003 Sep;136(3):454-63.PMID: 12967798 [PubMed - indexed for MEDLINE]Related articles

    11.

    Triamcinolone acetonide as an adjuvant in the surgical treatment of retinal detachment with proliferative vitreoretinopathy.

    Cheema RA, Peyman GA, Fang T, Jones A, Lukaris AD, Lim K.

    Ophthalmic Surg Lasers Imaging. 2007 Sep-Oct;38(5):365-70.PMID: 17955840 [PubMed - indexed for MEDLINE]Related articles

    12.

    Intravitreal crystalline triamcinolone acetonide as an additional tool in pars plana vitrectomy for complicated proliferative vitreoretinopathy?

    Jonas JB, Söfker A, Hayler J, Degenring RF.

    Acta Ophthalmol Scand. 2003 Dec;81(6):663-5. No abstract available. PMID: 14641276 [PubMed - indexed for MEDLINE]Related articles

    13.

    Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown.

    Sakamoto T, Miyazaki M, Hisatomi T, Nakamura T, Ueno A, Itaya K, Ishibashi T.

    Graefes Arch Clin Exp Ophthalmol. 2002 Jun;240(6):423-9. Epub 2002 Mar 15.PMID: 12107507 [PubMed - indexed for MEDLINE]Related articles

    14.

    Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study.

    Sonoda KH, Enaida H, Ueno A, Nakamura T, Kawano YI, Kubota T, Sakamoto T, Ishibashi T.

    Br J Ophthalmol. 2003 Aug;87(8):1010-4.PMID: 12881346 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    [Advantages and disadvantages of the circumferential retinal cryocoagulation before vitrectomy in proliferative diabetic vitreoretinopathy]

    Schulze S, Zaki N, Kroll P.

    Klin Monbl Augenheilkd. 2007 Aug;224(8):647-52. German. PMID: 17717781 [PubMed - indexed for MEDLINE]Related articles

    16.

    Intravitreal triamcinolone reduces the morphologic changes of ciliary body after pars plana vitrectomy for retinal vascular diseases.

    Lee GH, Ahn JK, Park YG.

    Am J Ophthalmol. 2008 Jun;145(6):1037-1044. Epub 2008 Apr 18.PMID: 18378211 [PubMed - indexed for MEDLINE]Related articles

    17.

    Acute endophthalmitis following intravitreal triamcinolone acetonide injection.

    Moshfeghi DM, Kaiser PK, Scott IU, Sears JE, Benz M, Sinesterra JP, Kaiser RS, Bakri SJ, Maturi RK, Belmont J, Beer PM, Murray TG, Quiroz-Mercado H, Mieler WF.

    Am J Ophthalmol. 2003 Nov;136(5):791-6.PMID: 14597028 [PubMed - indexed for MEDLINE]Related articles

    18.

    Delayed intraocular foreign body removal without endophthalmitis during Operations Iraqi Freedom and Enduring Freedom.

    Colyer MH, Weber ED, Weichel ED, Dick JS, Bower KS, Ward TP, Haller JA.

    Ophthalmology. 2007 Aug;114(8):1439-47. Epub 2007 Feb 28.PMID: 17331579 [PubMed - indexed for MEDLINE]Related articles

    19.

    Use of caffeic acid phenethyl ester and cortisone may prevent proliferative vitreoretinopathy.

    Turkoz Y, Er H, Borazan M, Yilmaz H, Mizrak B, Parlakpinar H, Cigremis Y.

    Mediators Inflamm. 2004 Apr;13(2):127-30.PMID: 15203555 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases]

    Jonas JB, Kreissig I, Kamppeter B, Degenring RF.

    Ophthalmologe. 2004 Feb;101(2):113-20. Review. German. PMID: 14991306 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity